OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

OBJECTIVE: Chronic migraine (CM) is a prevalent and disabling neurological disorder. Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical program assessed efficacy and safety of onabotulinumtoxinA (BOTOX®) for prophylaxis of headaches in adults with CM. This secondary analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Aurora, SK, Dodick, DW, Diener, H-C, DeGryse, RE, Turkel, CC, Lipton, RB, Silberstein, SD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033567/
https://www.ncbi.nlm.nih.gov/pubmed/24107267
http://dx.doi.org/10.1111/ane.12171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033567/
https://www.ncbi.nlm.nih.gov/pubmed/24107267
http://dx.doi.org/10.1111/ane.12171

Ejemplares similares